| ★ | AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD | | 129 | Estados Unidos | |
| 10 | ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD | | 60.1K | Estados Unidos | 58 |
| 15 | Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing | | 209 | Estados Unidos | 57 |
| 2 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 63 |
| 19 | How Much Hair Regrowth Did Upadacitinib Achieve in Severe Alopecia Areata? | | 196 | Estados Unidos | 56 |
| 11 | COMP360 Psilocybin's 26-Week Data in Treatment-Resistant Depression I Boadie Dunlop, MD | | 178 | Estados Unidos | 58 |
| 4 | SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo | | 174 | Estados Unidos | 60 |
| 13 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 58 |
| 1 | What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD | | 142 | Estados Unidos | 76 |
| 9 | Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease | ATS 2026 With Gerard Criner, MD | | 113 | Estados Unidos | 58 |
| 16 | Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension | | 112 | Estados Unidos | 57 |
| 17 | How to Sequence Omalizumab, Dupilumab, and Remibrutinib in CSU | | 74 | Estados Unidos | 57 |
| 5 | Avapritinib's 4-Year Impact on Quality of Life in ISM | Thanai Pongdee, MD | | 73 | Estados Unidos | 60 |
| 20 | 2026 Dyslipidemia Guidelines Redefine Treatment, Monitoring Strategies, With Roger Blumenthal, MD | | 71 | Estados Unidos | 56 |
| 3 | Addressing Advances and Roadblocks in Lipid Management, With Joseph Saseen, PharmD | | 64 | Estados Unidos | 62 |
| 12 | ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More | HCPLive Expert Interviews | | 55 | Estados Unidos | 58 |
| 18 | AI-CPA Plaque Assessment Results Consistent, Reproducible Among Observers | | 41 | Estados Unidos | 57 |
| 7 | Addressing the Manifold Barriers in Hypertension, With Michael Miedema, MD | | 27 | Estados Unidos | 59 |
| 14 | How ABCG2 Inhibition Could Change EPP Disease Management | | 17 | Estados Unidos | 58 |
| 6 | Speed Is the New Competitive Advantage in Lead Capture | Bright Plugins – WordPress & WooCommerce Plugins @brightpluginswp | 10 | Estados Unidos | 60 |
| 8 | Mitraa-T1D: AI-Driven Converastional Tool Improves T1D Diabetes Distress, Self-Care Behaviors | | 9 | Estados Unidos | 58 |